通过向MCL1来预防淋巴瘤细胞的恶性特征
Tengfei Shi1, Xiali Wu2, Aichun Liu1
1Hemolymph Department, Harbin Medical University Cancer Hospital, Harbin, China.
Hematological oncology
|August 29, 2025
概括
在扩散性大B细胞淋巴瘤 (DLBCL) 中,MicroRNA-29a-3p被降低调控,作为潜在的诊断标志物. 它针对MCL1抑制DLBCL细胞的活动,这表明它具有治疗作用.
科学领域:
- 分子瘤学
- 癌症生物学
- 微RNA疗法
背景情况:
- 扩散性大B细胞淋巴瘤 (DLBCL) 是一种常见的成人淋巴瘤.
- 微RNA (miRNA) 越来越多地被认为对癌症的发展起作用.
- 了解miR-29a-3p在DLBCL中的功能可以提供新的治疗策略.
研究的目的:
- 研究DLBCL中的miR-29a-3p的表达和机制.
- 评估miR-29a-3p作为DLBCL诊断和监测的潜在生物标志物.
- 探索调节miR-29a-3p/MCL1轴的治疗潜力.
主要方法:
- 定量PCR (qPCR) 用于确定DLBCL组织,血清和细胞中的miR-29a-3p水平.
- 用于诊断潜力的接收器操作特征 (ROC) 曲线分析.
- 双化酶试验以验证MCL1作为miR-29a-3p的标.
- 转染试验用于操纵miR-29a-3p和MCL1的表达,其次是细胞增殖 (CCK-8),迁移 (Transwell) 和亡试验 (流细胞计).
主要成果:
- 在DLBCL样本中,miR- 29a- 3p显著下调.
- 通过ROC分析,miR- 29a- 3p对DLBCL患者的查具有很大的潜力.
- 证实MCL1是miR- 29a- 3p的直接点,在DLBCL中表达过度.
- 恢复miR- 29a- 3p抑制了DLBCL细胞的增殖和迁移,这种效应因MCL1过度表达而被部分逆转.
结论:
- 低调 miR-29a-3p 是DLBCL的一个特征,表明其作为生物标志物的有用性.
- 在调节DLBCL细胞行为方面,miR-29a-3p/MCL1的相互作用至关重要.
- miR-29a-3p/MCL1轴代表了DLBCL的一个有前途的治疗标和监测标记.
相关概念视频
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
MicroRNAs
21.7K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.7K
Induced Pluripotent Stem Cells
4.4K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.4K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Receptor Downregulation in MVBs
2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.1K
Negative Regulator Molecules
35.9K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.9K


